Abstract
The complexity of the current threat landscape associated with terrorism and criminal networks continues to be a top national and global security agenda item. Amongst the global security challenges, synthetic drugs constitute one of the most significant drug problems worldwide (UNODC in Global smart update: fentanyl and its analogous—50 years on, 2017 [54]). Fentanyl and non-pharmaceutical fentanyls (NPFs) have moved beyond being a concern to emerging as a national and global security matter. In 2015, more than 52,000 Americans (144/day) died from drug overdose. As reported by Chester (Fentanyl: the next wave of the opioid crisis, 2017 [9]), 63% of overdoses involved opioids whereby they are having ‘…a considerable impact on public health and public safety in communities across the United States’. In Canada, the Fentanyl-related deaths has markedly increased across British Columbia, Alberta, Ontario and Quebec, ranging from a doubling to 20-fold increase from 2009 to 2014 (CCENDU in Deaths involving fentanyl in Canada, 2009–2014, 2015 [4]). This increasing trend is noted internationally with increasing mortality in Australia (Roxburgh et al. in Drug Alcohol Rev 32:269–275, 2013 [48]) and the Nordic countries (Denmark, Finland, Iceland, Norway, Sweden) (Simonsen et al. in Forensic Sci Int 248:172–180, 2015 [50]). Richmond (An introduction to systems thinking. High Performance Systems, Inc. NH: Hanover, 2001 [46]) argues that ‘The way we think is outdated. As a result, the way we act creates problems, and then we are ill-equipped to address them because of the way we think’. His argument stems from the ‘…fact that we have been applying the same set of non-solutions to the crucial social problems such as drugs, poverty and crime for most of the last fifty years without any positive results’. This chapter examines the national and global fentanyl crisis and introduces a holistic perspective of the problem space that leverages social innovation and macro-social analysis (Boivin in Networks and network analysis for defence and security. Springer, Berlin, 2014 [1]; Masys in Exploring the security landscape—non-traditional security challenges. Springer, Berlin, 2016 [37]) to examine the public health and criminal dimensions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boivin R (2014) Macrosocial network analysis: the case of transnational drug trafficking. In: Masys AJ (ed) Networks and network analysis for defence and security. Springer, Berlin
Bruinsma G, Bernasco W (2004) Criminal groups and transnational illegal markets. Crime, Law, Soc Change 41:79–94
CFR (2017) The growing U.S. opioid crisis: lessons from around the world. https://www.cfr.org/event/growing-us-opioid-crisis-lessons-around-world
Canadian Community Epidemiology Network on Drug Use (CCENDU) (2015) Deaths involving fentanyl in Canada, 2009–2014. Ottawa, Ontario
Canadian Pharmacists Association (CPhA) (2017) Environmental scan: access to naloxone across Canada. Ottawa, Ontario
Carney A (2017) The current national opioid crisis: conceptualizing a plan of action. http://inquirepublication.com/the-current-national-opioid-crisis-conceptualizing-a-plan-of-action/
Centers for Disease Control and Prevention (CDC) (2017a) Fentanyl: preventing occupational exposure to emergency responders. https://www.cdc.gov/niosh/topics/fentanyl/risk.html
Centers for Disease Control and Prevention (CDC) (2017b) Opioid data analysis. https://www.cdc.gov/drugoverdose/data/analysis.html
Chester KL (2017) Fentanyl: the next wave of the opioid crisis. Subcommittee on oversight and investigations committee on energy and commerce United States house of representatives. http://docs.house.gov/meetings/IF/IF02/20170321/105739/HHRG-115-IF02-Wstate-ChesterK-20170321.pdf
Cobaugh DJ, Gainor C, Gaston CL, Kwong TC et al (2014) The opioid abuse and misuse epidemic: implications for pharmacists and health systems. Am J Health Syst Pharm 71:1539–1554
DODAF (2015) DODAF V 2.0. Volume II: Architectural data and models. Available at: http://dodcio.defense.gov/Portals/0/Documents/DODAF2/DoDAF%20v2.02%20Chg%201%20Vol%20II%20Final%202015-01-19.pdf [accessed 11 Oct 2015]
Drewes AM, Jensen RD, Nielsen LM, Droney J et al (2013) Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol 75:60–78
Duijn PAC, Sloot PMA (2015) From data to disruption. Digit Invest 15:39–45
Duijn PAC, Klerks PPHM (2014) Social network analysis applied to criminal networks: recent developments in Dutch law enforcement. In Masys AJ (ed) Networks and network analysis for defence and security. Springer
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016) Preventing OPIOID overdose deaths with take-home Naloxone. http://www.emcdda.europa.eu/system/files/attachments/2092/News%20release_1_EN_2016_Naloxone_Final.pdf
Farrell M (2014) Drug legalisation. BMJ 349:g5233
Feng Y, He X, Yang Y, Chao D et al (2012) Current research on opioid receptor function. Curr Drug Targets 13:230–246
Fischer B, Russell C, Murphy Y, Kurdyak P (2015) Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis? Pharmacoepidemiol Drug Saf 24:1334–1336
Florence CS, Zhou C, Luo F, Xu L (2016) The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care 54:901–906
Frank RG, Pollack HA (2017) Addressing the fentanyl threat to public health. NEJM 376(7):605–607
Friesen KJ, Woelk C, Bugden S (2016) Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches. Can Med Assoc J 188:648–653
Gladden RM, Martinez P, Seth P (2016) Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths—27 states, 2013–2014. Centers Dis Control Prev MMWR 65(33):837–843
Goldin I, Mariathasan M (2014) The butterfly defect: how globalization creates systemic risks and what to do about it. Princeton University Press, Princeton, NJ
Halliday JEB, Hampson K, Hanley N, Lembo T, Sharp JP, Haydon DT, Cleaveland S (2017) Driving improvements in emerging disease surveillance through locally relevant capacity strengthening. Science 357(6347):146–148
International Narcotics Control Board (2016) Narcotic Drugs 2016. https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2016/Narcotic_Drugs_Publication_2016.pdf
Janssen Inc. (2017) Product monograph: Duragesic. Markham, Ontario
Kanjhan R (1995) Opioids and pain. Clin Exp Pharmacol Physiol 22:397–403
Kaundert M, Masys AJ (2018) Mass migration, humanitarian assistance and crisis management: embracing social innovation and organizational learning. In: Masys AJ (ed) Security by design. Springer Publishing
Kerensky T, Walley AY (2017) Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know. Addict Sci Clin Pract 12:4
Levi M, Maguire M (2004) Reducing and preventing organised crime: an evidence-based critique. Crime, Law Soc Change 41: 397–469
Lotsch J, Walter C, Parnham MJ, Oertel BG et al (2013) Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet 53:23–36
Marquardt KA, Tharratt RS, Musallam NA (1995) Fentanyl remaining in a transdermal system following three days of continuous use. Ann Pharmacother 29:969–971
Masys AJ (ed) (2015) Applications of systems thinking and soft operations research in managing complexity. Springer Publishing
Masys AJ (2016) Disrupting terrorist and criminal networks: crime script analysis through DODAF applications. In: Masys AJ (ed) Exploring the security landscape—non-traditional security challenges. Springer, Berlin
Meda Pharmaceuticals Inc. (2012) Product monograph: Onsolis. Solna, Sweden
Moore M, Westley F (2011) Surmountable chasms: networks and social innovation for resilient systems. Ecology and Society 16(1):5. [online] URL: http://www.ecologyandsociety.org/vol16/iss1/art5/
Mounteney J, Giraudon I, Denissov G, Griffiths P (2015) Fentanyls: are we missing the signs? Highly potent and on the rise in Europe. Int J Drug Policy 26:626–631
Murray R, Caulier-Grice J, Mulgan G (2010) The open book of social innovation. Nesta
Nicholls A, Simon J, Gabriel M (2015) Introduction: dimensions of social innovation. In: Nicholls A, Simon J, Gabriel M (eds) New frontiers in social innovation research. Palgrave Macmillan
O’Connor S (2017) Fentanyl: China’s deadly export to the United States. U.S.-China economic and security review commission. https://www.uscc.gov/sites/default/files/Research/USCC%20Staff%20Report_Fentanyl-China%E2%80%99s%20Deadly%20Export%20to%20the%20United%20States020117.pdf
Paladin Labs Inc. (2017) Product monograph: abstral. St-Laurent, Quebec
Patton MQ (2011) Developmental evaluation: applying complexity concepts to enhance innovation and use. Guilford Press, New York
Pereira J, Lawlor P, Vigano A, Dorgan M et al (2001) Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 22:672–687
Phills JA, Deiglmeier K, Miller DT (2008) Rediscovering social innovation. Stanford Soc Innov Rev Fall 2008: 34–43
Prekupec MP, Mansky PA, Baumann MH (2017) Misuse of novel synthetic opioids: a deadly new trend. J Addict Med 11(4):256–265
Richmond B (2001) An introduction to systems thinking (iThink software). High Performance Systems, Inc. NH: Hanover
Roberts N, Everton SF (2011) Strategies for combatting dark networks. J Soc Struct 12(2). http://www.cmu.edu/joss/content/articles/volume12//RobertsEverton.pdf
Roxburgh A, Burns L, Drummer OH, Pilgrim J et al (2013) Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. Drug Alcohol Rev 32:269–275
Sandoz Canada Inc. (2013) Product Monograph: Fentanyl Citrate Injection. Boucherville, Quebec
Simonsen KW, Edvardsen HM, Thelander G, Ojanpera I et al (2015) Fatal poisoning in drugs addicts in the Nordic countries in 2012. Forensic Sci Int 248:172–180
Stanley TH (2014) The fentanyl story. J Pain 15:1215–1226
Suzuki J, El-Haddad S (2017) A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend 171(2017):107–116
Trescot AM, Datta S, Lee M, Hansen H (2008) Opioid pharmacology. Pain Physician 11:S133–S153
UNODC (2017) Global smart update: fentanyl and its analogous—50 years on. https://www.unodc.org/documents/scientific/Global_SMART_Update_17_web.pdf
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Tsang, C., Masys, A.J. (2018). Fentanyl Crisis: A National Security Matter. In: Masys, A. (eds) Security by Design. Advanced Sciences and Technologies for Security Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-78021-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-78021-4_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78020-7
Online ISBN: 978-3-319-78021-4
eBook Packages: Law and CriminologyLaw and Criminology (R0)